Literature DB >> 14986792

Ampullary adenoma: clinical manifestations, diagnosis, and treatment.

John A Martin1, Gregory B Haber.   

Abstract

Ampullary adenomas occur sporadically and in the setting of familial polyposis syndromes. In either case, and whether symptomatic at presentation or found asymptomatically in the setting of endoscopic screening programs, they are premalignant lesions with risk for malignant degeneration to carcinoma following the adenoma-to-carcinoma sequence that is well recognized in colonic adenocarcinoma. Accordingly, many experts advocate excision, although others cite the low rate of histologic progression suggested by some recent studies as justification for close endoscopic surveillance rather than excision before demonstration of dysplastic change. This recommendation, however, is complicated by considerable data underscoring the limited accuracy of endoscopic forceps biopsy in detecting occult foci of carcinoma within ampullary adenoma. Thus, the optimal management of these lesions continues to generate considerable controversy. Indications for excision of an ampullary adenoma include treatment of immediate symptoms as well as prevention of malignant degeneration. Although pancreaticoduodenectomy has long been considered the standard procedure for ampullary carcinoma, much controversy exists regarding the procedure of choice for ampullary adenoma. Radical surgery (pancreaticoduodenectomy) possesses the advantage of low recurrence rate but at the expense of higher morbidity (25%-65%) and mortality (0%-10%). Local surgical excision (surgical ampullectomy) possesses the advantages of lower morbidity (0%-25%), essentially nil mortality, and possibly decreased length of hospital stay, but decidedly higher recurrence rates (generally 5%-30%) and the need for postoperative endoscopic surveillance. Snare ampullectomy is a newer endoscopic excisional technique for which limited data are available; advantages compared with radical surgery mirror those of local surgical excision, with apparent lower mortality (0%-1%) and lower morbidity (12%). Presumed advantages compared with local surgical excision include lack of necessity for general anesthesia and laparotomy with comparable morbidity. Disadvantages seem to include limited availability of experienced operators, procedural complexity sometimes requiring adjunctive modalities such as fulguration, the need for multiple procedures (mean, 2.0 procedures) to effect complete excision, and recurrence rates approaching 30%, with a requirement for continued endoscopic surveillance. Ultimately, choice is driven by availability of local expertise, patient tolerance of or expected compliance with long-term endoscopic surveillance programs, presence or absence of coexisting familial polyposis syndromes, medical comorbidities, and overall life expectancy.

Entities:  

Mesh:

Year:  2003        PMID: 14986792     DOI: 10.1016/s1052-5157(03)00101-6

Source DB:  PubMed          Journal:  Gastrointest Endosc Clin N Am        ISSN: 1052-5157


  23 in total

Review 1.  Endoscopic management of adenomatous ampullary lesions.

Authors:  Jesús Espinel; Eugenia Pinedo; Vanesa Ojeda; Maria Guerra Del Rio
Journal:  World J Methodol       Date:  2015-09-26

2.  Management of ampullary lesions.

Authors:  George W Dittrick; Damien B Mallat; Jeffrey P Lamont
Journal:  Curr Treat Options Gastroenterol       Date:  2006-09

3.  Endoscopic resection of ampullary lesions: a single-center 8-year retrospective cohort study of 91 patients with long-term follow-up.

Authors:  Wim Laleman; Annelies Verreth; Baki Topal; Raymond Aerts; Mina Komuta; Tania Roskams; Schalk Van der Merwe; David Cassiman; Frederik Nevens; Chris Verslype; Werner Van Steenbergen
Journal:  Surg Endosc       Date:  2013-05-25       Impact factor: 4.584

4.  Endoscopic papillectomy for neoplastic ampullary lesions: A systematic review with pooled analysis.

Authors:  Marco Spadaccini; Alessandro Fugazza; Leonardo Frazzoni; Milena Di Leo; Francesco Auriemma; Silvia Carrara; Roberta Maselli; Piera Alessia Galtieri; Viveksandeep Thoguluva Chandrasekar; Lorenzo Fuccio; Emad Aljahdli; Cesare Hassan; Prateek Sharma; Andrea Anderloni; Alessandro Repici
Journal:  United European Gastroenterol J       Date:  2019-07-30       Impact factor: 4.623

5.  A single-institution review of 157 patients presenting with benign and malignant tumors of the ampulla of Vater: management and outcomes.

Authors:  John R Hornick; Fabian M Johnston; Peter O Simon; Morgan Younkin; Michael Chamberlin; Jonathan B Mitchem; Riad R Azar; David C Linehan; Steven M Strasberg; Steven A Edmundowicz; William G Hawkins
Journal:  Surgery       Date:  2011-08       Impact factor: 3.982

6.  Long-Term Outcomes of Endoscopic Papillectomy for Ampullary Adenomas.

Authors:  Nadav Sahar; Rajesh Krishnamoorthi; Richard A Kozarek; Michael Gluck; Michael Larsen; Andrew S Ross; Shayan Irani
Journal:  Dig Dis Sci       Date:  2019-08-28       Impact factor: 3.199

7.  Endoscopic papillectomy: risk factors for incomplete resection and recurrence during long-term follow-up.

Authors:  Wiriyaporn Ridtitid; Damien Tan; Suzette E Schmidt; Evan L Fogel; Lee McHenry; James L Watkins; Glen A Lehman; Stuart Sherman; Gregory A Coté
Journal:  Gastrointest Endosc       Date:  2013-10-01       Impact factor: 9.427

Review 8.  Evaluation and management of periampullary tumors.

Authors:  William A Ross; Mike M Bismar
Journal:  Curr Gastroenterol Rep       Date:  2004-10

9.  Immunocytochemical assessment of p53 protein to detect malignancy in increased cell-yield brush cytology from the biliopancreatic tree.

Authors:  Vincenzo Villanacci; Renzo Cestari; Stefano Giulini; Paolo Cengia; Guido Missale; Angiola Berenzi; Elisa Rossi; Massimo Bonardi; Luca Baiocchi; Gabrio Bassotti
Journal:  Dig Dis Sci       Date:  2008-08-08       Impact factor: 3.199

10.  A survey of ampullectomy practices.

Authors:  Stacy B Menees; Philip Schoenfeld; Hyungjin Myra Kim; Grace H Elta
Journal:  World J Gastroenterol       Date:  2009-07-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.